Jan G.P. Tijssen

Showing 1-6 of 6 articles

Author Laura S.M. Kerkmeijer

Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent in routine PCI: three-year clinical outcomes from the AIDA trial

Kerkmeijer L, Tijssen R, Hofma S, van der Schaaf R, Arkenbout K, Kraak R, Weevers A, Piek J, de Winter R.J, Tijssen J, Henriques J, Wykrzykowska J, Ijsselmuiden A, Kauer F, Beijk M, Vis M, Koch K

May 23, 2019 | 10.4244/EIJ-D-19-00325

Author Ruben Y.G. Tijssen

Complete two-year follow-up with formal non-inferiority testing on primary outcomes of the AIDA trial comparing the Absorb bioresorbable scaffold with the XIENCE drug-eluting metallic stent in routine PCI

Tijssen RY, Kraak R, Hofma S, van der Schaaf R, Arkenbout E, Weevers A, Elias J, van Dongen I, Koch K, Baan Jr J, Vis M, de Winter R.J, Piek J, Tijssen J, Henriques J, Wykrzykowska J

July 20, 2018 | 10.4244/EIJ-D-18-00335

Author Ruben Y.G. Tijssen

Coronary interventions

Implantation techniques (predilatation, sizing, and post-dilatation) and the incidence of scaffold thrombosis and revascularisation in lesions treated with an everolimus-eluting bioresorbable vascular scaffold: insights from the AIDA trial

Tijssen RY, Kraak R, Elias J, van Dongen I, Kalkman D, Nassif M, Sotomi Y, Asano T, Katagiri Y, Collet C, Piek J, Henriques J, de Winter R.J, Tijssen J, Onuma Y, Serruys P, Wykrzykowska J

July 20, 2018 | 10.4244/EIJ-D-17-01152

Author Koen Teeuwen

Coronary interventions

Optical coherence tomography findings: insights from the “randomised multicentre trial investigating angiographic outcomes of hybrid sirolimus-eluting stents with biodegradable polymer compared with everolimus-eluting stents with durable polymer in chronic total occlusions” (PRISON IV) trial

Teeuwen K, Spoormans E, Bennett J, Dubois C, Desmet W, Ughi G, Belmans A, Kelder J, Tijssen J, Agostoni P, Suttorp MJ, Adrianssens T

August 4, 2017 | 10.4244/EIJ-D-17-00261

Author Mariella E.C.J. Hassell

Coronary interventions

Microvascular dysfunction following ST-elevation myocardial infarction and its recovery over time

Hassell M, Bax M, van Lavieren M, Nijveldt R, Hirsch A, Robbers L, Marques K, Tijssen J, Zijlstra F, van Rossum A, Delewi R, Piek J

August 4, 2017 | 10.4244/EIJ-D-16-00818

Author Milan Milojevic

Coronary interventions

Hierarchical testing of composite endpoints: applying the win ratio to percutaneous coronary intervention versus coronary artery bypass grafting in the SYNTAX trial

Milojevic M, Head S, Andrinopoulou E, Serruys P, Mohr F, Tijssen J, Kappetein AP

May 15, 2017 | 10.4244/EIJ-D-16-00745

1

Latest news

Percutaneous recanalisation of CTO, FAST-TAVI trial, substudy from DANAMI-3-PRIMULTI... discover the latest issue

Computation of OFR by OCT on a LAD with physiologically non-significant stenosis.

Guidance papers

Clinical use of intracoronary imaging Part 2

Read this consensus to appraise ACS, ambiguous coronary angio findings and interventional decision-making

New this week: BIOFLOW-IV RCT, Computed Tomography Cardiac Angiography and FU of patients with aortic arch atresia

Last Update: Augustus, PARTNER III, NOTION...

(The Trials book is supported by Biotronik)

Late breaking trials

Access the Late Breaking Trials published at EuroPCR 2019

Guidance papers

Guidelines, consensus & position papers

Hot topic: access the proceedings from the CRT 2019 Town Hall meeting

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke